Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19–14)

Choong‐kun Lee, Hong Jae Chon, Jaekyung Cheon, +12

˜The œLancet. Gastroenterology & hepatology

Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib

Chung Ryul Oh, Sun‐Young Kong, Hyeon-Su Im, +9

BMC Cancer

Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: a multicenter retrospective study of the Korean Cancer Study Group (KCSG)

H.S. Park, Beodeul Kang, Hong Jae Chon, +16

ESMO Open

HSP90 inhibitor, AUY922, debilitates intrinsic and acquired lapatinib-resistant HER2-positive gastric cancer cells

Kang‐Seo Park, Yong Sang Hong, Junyoung Choi, +10

BMB Reports

Unmet needs related to the quality of life of advanced cancer patients in Korea: a qualitative study

Jeehee Pyo, Minsu Ock, Mina Lee, +8

BMC Palliative Care

Changes in decision-making process for life-sustaining treatment in patients with advanced cancer after the life-sustaining treatment decisions-making act

Hyeyeong Kim, Hyeon-Su Im, Kyong Og Lee, +8

BMC Palliative Care

Rivaroxaban <i>Versus</i> Low-molecular-weight Heparin for Venous Thromboembolism in Advanced Upper Gastrointestinal Tract and Hepatopancreatobiliary Cancer

Jwa Hoon Kim, Seyoung Seo, Kyu‐pyo Kim, +9

In Vivo

Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy

Kyunghye Bang, Jaekyung Cheon, Jae Ho Jeong, +4

Therapeutic Advances in Medical Oncology

Perceptions of the meaning of life among Korean patients with advanced cancer: A mixed-methods study

Su‐Jin Koh, Kyung‐Ah Kang, Hyeyeong Kim, +6

Palliative & Supportive Care